The World health Organisation has suspended the approval of Tuberculosis drugs made by Indias Svizera Labs, a major supplier to developing countries following an investigation into standards.
The United Nation agency which acts as a drug watchdog in market said that it had suspended all its TB products made at Svizera’s Mumbai site because manufacturing standards and quality management were unreliable.
It also said that independent agencies should retest batches of medicines already on the market and it might be necessary to recall supplies, depending on the outcome of those tests.
This is a fresh blow for India’s pharmaceuticals industries cheap generic medicines to countries worldwide but has been tarnished by series of quality problem in recent times.
